BIOGEN News & Analysis

American Century Investments' low-turnover strategy invests in companies developing vaccines, treatments for neuro-cognitive diseases and innovations...

By 2050, almost 20 per cent of the global population will be over 65 and demand for healthcare will climb, says Michael Li of American Century...

Morningstar's Karen Andersen explains how environmental, social and governance issues affect Big Pharma and biotech companies.